Vivani Medical, Inc. (VANI)
$1.39-$0.03 (-2.18%) Today
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 2,380,951 | $3.00M |
| Grant or award | 16 | 1,067,529 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
47 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aaron Mendelsohn - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 35,135 | $1.27 | $45K | |
| Alexandra L. Popoff - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 35,135 | $1.27 | $45K | |
| Anthony Baldor - Officer | Grant or award | Common Stock Option | 600,000 | $0.00 | - | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 3,499 | $1.01 | $4K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 6,836 | $1.01 | $7K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 2,405 | $1.01 | $2K | |
| Brigid Makes - Officer | Grant or award | Common Stock Option | 75,000 | $0.00 | - | |
| Brigid Makes - Officer | Grant or award | RSUs | 37,500 | $0.00 | - | |
| Adam Mendelsohn - Officer | Grant or award | Common Stock Option | 200,000 | $0.00 | - | |
| Adam Mendelsohn - Officer | Grant or award | RSUs | 100,000 | $0.00 | - | |
| Donald Dwyer - Officer | Grant or award | Common Stock Option | 70,000 | $0.00 | - | |
| Donald Dwyer - Officer | Grant or award | RSUs | 35,000 | $0.00 | - | |
| Truc le - Officer | Grant or award | Common Stock Option | 160,000 | $0.00 | - | |
| Truc le - Officer | Grant or award | RSUs | 80,000 | $0.00 | - | |
| Lisa Ellen Porter - Officer | Grant or award | Common Stock Option | 80,000 | $0.00 | - | |
| Lisa Ellen Porter - Officer | Grant or award | RSUs | 40,000 | $0.00 | - | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 1,113 | $1.01 | $1K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 1,569 | $1.01 | $2K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 243 | $1.01 | $245 | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 18,529 | $1.02 | $19K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 2,311 | $1.01 | $2K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 34,000 | $0.99 | $34K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 44,400 | $0.99 | $44K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 5,600 | $0.98 | $5K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 58,583 | $0.99 | $58K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 62,899 | $1.02 | $64K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 2,000 | $1.01 | $2K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 22,939 | $1.00 | $23K | |
| Donald Dwyer - Officer | Open-market purchase | Common Stock | 4,000 | $1.03 | $4K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 3,968,253 | $1.26 | $5.00M | |
| Donald Dwyer - Officer | Open-market purchase | Common Stock | 1,000 | $1.14 | $1K | |
| Donald Dwyer - Officer | Open-market purchase | Common Stock | 1,000 | $1.13 | $1K | |
| Donald Dwyer - Officer | Open-market purchase | Common Stock | 500 | $1.13 | $565 |
This is as far as the anonymous view goes. Create a free account for all 47 VANI filings on record.
Vivani Medical, Inc. (VANI) had 13 insider filings in the last 90 days, with the most recent on 2026-07-31. The full record for VANI runs to 47 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of VANI were filed in the last 90 days, totaling $3.00M.
No insider sales of VANI were filed in the last 90 days.
This page tracks VANI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add VANI to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
